# Phase I Trial of 225Ac-J591 in Patients With mCRPC

> **NCT03276572** · PHASE1 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 32 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 225Ac-J591

## Key facts

- **NCT ID:** NCT03276572
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-10
- **Primary completion:** 2021-01-07
- **Final completion:** 2023-09-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03276572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03276572, "Phase I Trial of 225Ac-J591 in Patients With mCRPC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03276572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*